S'abonner

Predictive criteria of response to endoscopic treatment for severe strictures in primary sclerosing cholangitis - 25/07/19

Doi : 10.1016/j.clinre.2019.01.003 
Nora Cazzagon a, b, Olivier Chazouillères a, Christophe Corpechot a, Sanaâ El Mouhadi c, Edouard Chambenois c, Benoit Desaint a, d, Ulriikka Chaput a, d, Sara Lemoinne a, Lionel Arrivé c,
a Reference center for inflammatory biliary disease and autoimmune hepatitis (MIVB), Saint-Antoine Hospital, Assistance Publique-Hôpitaux de Paris, AP–HP, 75012 Paris, France 
b Department of Surgery, Oncology and Gastroenterology (DiSCOG), University of Padova, Padova, Italy 
c Department of Radiology, Saint-Antoine Hospital, Assistance Publique-Hôpitaux de Paris AP–HP, Sorbonne university, 75012 Paris, France 
d Endoscopic department, Saint-Antoine Hospital, Assistance Publique-Hôpitaux de Paris, AP–HP, Paris, France 

Corresponding author at: Department of Radiology, Saint-Antoine Hospital, 184 rue du Faubourg-Saint-Antoine, 75012 Paris, France.Department of Radiology, Saint-Antoine Hospital184 rue du Faubourg-Saint-AntoineParis75012France

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

pages 8
Iconographies 2
Vidéos 0
Autres 0

Highlights

In patients with primary sclerosing cholangitis (PSC), there is a need of objective predictive criteria of improvement after endoscopic treatment, especially in case of severe stricture without acute clinical manifestation (jaundice or acute cholangitis).
Features of magnetic resonance cholangiography, performed before endoscopic treatment, were evaluated according to a standard model of interpretation and a radiologic qualitative score of probability of improvement after endoscopic treatment was built.
Score 3 (improvement likely) was given in case of severe common bile duct stricture with marked dilatation without severe strictures of upstream ducts, score 1 (improvement unlikely) was given in case of severe multiple strictures of secondary ducts without biliary dilatation and score 2 (undeterminate) was given to an intermediate pattern.
Short left hepatic duct stricture, bilirubin, transaminases, pruritus and score 3 (improvement likely) were associated with response to endoscopic treatment.
Magnetic resonance cholangiography, together with biochemical features, may contribute to identify patients with PSC who are likely to be improved after endoscopic treatment for severe strictures of extrahepatic bile ducts.
A validation in a larger cohort is warranted to confirm these results, especially in patients without an evident indication to endoscopic treatment.

Le texte complet de cet article est disponible en PDF.

Summary

Background

The aim of this study was to identify predictive criteria of improvement after endoscopic treatment (ET) for severe strictures of extrahepatic bile ducts in patients with primary sclerosing cholangitis (PSC).

Methods

PSC patients who had at least one ET for severe stricture were included. Features of magnetic resonance cholangiography (MRC), performed before ET, were evaluated according to a standard model of interpretation, and a radiologic qualitative score of probability of improvement after ET was built. Score 3 (likely) was given in case of severe common bile duct (CBD) stricture with marked dilatation without severe strictures of upstream ducts, Score 1 (unlikely) was given in case of severe multiple strictures of secondary ducts without biliary dilatation and Score 2 (undeterminate) was given to an intermediate pattern. The response to ET was assessed at 2 months (T2-response) from the last ET and at 12 months (T12-response) from inclusion.

Results

Thirty-one patients were included. All had severe stricture (reduction ≥ 75% of the diameter) of CBD and 50% had severe stricture of right and/or left hepatic duct (LHD) at MRC before ET. According to the qualitative score, 16 patients had Score 3, 7 had Score 1 and 9 had Score 2. T12-response was obtained in 50% of patients. In univariate analysis, short LHD strictures, bilirubin, transaminases, pruritus and Score 3 were associated with T12-response. Increased bilirubin and transaminases were independent predictive factors of T12-response (HR 24, 95% CI: 3.4–170.4, P = 0.001 and 23.8, 95% CI: 3.4–169.4, P = 0.002, respectively).

Conclusion

MRC, together with biochemical features, may contribute to identify the PSC patients who are likely to be improved after ET for severe strictures of extrahepatic bile ducts.

Le texte complet de cet article est disponible en PDF.

Keywords : Dominant stenosis, Endoscopic retrograde cholangiopancreatography, Magnetic resonance imaging, Sensitivity and specificity


Plan


© 2019  Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 43 - N° 4

P. 387-394 - août 2019 Retour au numéro
Article précédent Article précédent
  • Interplay of Wnt ?-catenin pathway and miRNAs in HBV pathogenesis leading to HCC
  • Muhammad Adeel Rana, Bushra Ijaz, Muhammad Daud, Sommyya Tariq, Tariq Nadeem, Tayyab Husnain
| Article suivant Article suivant
  • Portal vein thrombosis and liver cirrhosis: Long-term anticoagulation is effective and safe
  • Michel Bergère, Domitille Erard-Poinsot, Olivier Boillot, Pierre-Jean Valette, Olivier Guillaud, Christine Chambon-Augoyard, Jérôme Dumortier

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2025 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.